Package 46287-030-01

Brand: atorvaliq

Generic: atorvaliq
NDC Package

Package Facts

Identity

Package NDC 46287-030-01
Digits Only 4628703001
Product NDC 46287-030
Product ID 46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895
Description

150 mL in 1 BOTTLE (46287-030-01)

Marketing

Marketing Status
Marketed Since 2023-03-01
Brand atorvaliq
Generic atorvaliq
Sample Package No

Linked Drug Pages (1)

ATORVALIQ ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb92775a-6d6d-4d62-ab23-045f16ec5895", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["2630760"], "spl_set_id": ["41fca2d8-7f3f-45b9-8974-81b89accc211"], "manufacturer_name": ["CMP Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (46287-030-01)", "package_ndc": "46287-030-01", "marketing_start_date": "20230301"}], "brand_name": "ATORVALIQ", "product_id": "46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895", "dosage_form": "SUSPENSION", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "46287-030", "generic_name": "ATORVALIQ", "labeler_name": "CMP Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVALIQ", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "20 mg/5mL"}], "application_number": "NDA213260", "marketing_category": "NDA", "marketing_start_date": "20230301", "listing_expiration_date": "20261231"}